ArticleMaterials today. Bio2025
Additive-free hyaluronic acid-based bioink for 3D bioprinting of bone marrow microenvironments.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioprinting of soft tissues is an emerging technology with significant potential in regenerative medicine. It requires bioinks that mimic biochemical and physical properties of natural tissues and enable precise positioning of multiple cell types to allow their physiological interplay. Here, we describe the development of a bioink for bone marrow as an example of soft tissue. Bone marrow is the site of blood regeneration, driven by hematopoietic stem cells (HSCs) and relying on the orchestrated interplay of hematopoietic and stromal cells in a soft microenvironment. The bioink is based on hyaluronic acid (HA), dual-functionalized in a one-pot synthesis with alkyl side chains enhancing physical crosslinking via hydrophobic interactions and methacrylamide groups allowing covalent photo-crosslinking. Polymers are synthesized with HA of differing molecular weights, alkyl side chain lengths and modification degrees. Their gelling behavior, shear-thinning and self-healing properties deem them suitable for extrusion-based bioprinting. The ink allows two bioprinting approaches: cell encapsulation pre-printing and cell injection post-printing, both yielding excellent cell viability. The latter approach allows precise placement of hematopoietic and stromal cells in a single construct. In summary, we present a bioink enabling bioprinting of modified HA without further additives, bioprinting of encapsulated cells and injection of cells into pre-printed structures. The material is based on a polymer naturally present in bone marrow, resembles the mechanical properties of bone marrow and is suitable for bioprinting of hematopoietic and stromal cells. Thus, this bioink is a promising platform for bioprinting biomimetic bone marrow or other soft tissue constructs for future fundamental and applied research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.